하울바이오

HaulBio is a South Korean biotechnology company specializing in the development of next-generation antibody therapeutics and diagnostic solutions. The company leverages its proprietary "Haul-Body" platform to create multi-specific antibodies and "Haul-Linker" technology for advanced antibody-drug conjugates (ADCs). Their research focus primarily targets oncology and infectious diseases, aiming to overcome the limitations of existing monoclonal antibody treatments. In addition to therapeutics, HaulBio develops high-sensitivity diagnostic kits for rapid disease detection and point-of-care testing. The company is actively expanding its pipeline through strategic collaborations and government-backed research initiatives.